- HOME
- Rinsho Shinkeigaku (Clinical Neurology)
- Vol.48 No.11
Vol.48 No.11 contents
The 49th Annual Meeting of the Japanese Society of Neurology
Migrainology learned from patients
Fumihiko Sakai, M.D.
CLINICA NEUROL, 48: 785|791, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Neuroscience in Japan: Its charm and challenge for future generations
Jun Kimura, M.D.
CLINICA NEUROL, 48: 792|797, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Molecular Mechanism of Migraine
Michael A. Moskowitz
CLINICA NEUROL, 48: 798|798, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Paraneoplastic Disorders of the Nervous System
Josep Dalmau, MD, PhD
CLINICA NEUROL, 48: 799|803, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Neuropathological perspective on single slide
Asao Hirano, M.D.
CLINICA NEUROL, 48: 804|808, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Reorienting health systems in the 21st century: the WHO Perspective
Linda L. Milan, M.D., M.P.H.
CLINICA NEUROL, 48: 809|814, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Toward a future Research in Neurology: molecular analysis of brain disorder
Katsuhiko Mikoshiba, M.D., Ph.D.
CLINICA NEUROL, 48: 815|820, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 821|822, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Molecular and genetic analysis of spinocerebellar ataxia type 10 (SCA10)
Tohru Matsuura, M.D.
CLINICA NEUROL, 48: 823|825, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Construction of regional system in support of homecare -What's required for clinical neurologist from patients-
Yoh Horikawa, M.D.
CLINICA NEUROL, 48: 826|830, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies
Satoshi Orimo, M.D.
CLINICA NEUROL, 48: 831|834, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Treatment of Parkinson's disease at present and in the future
Shigeki Kuzuhara, M.D., Ph.D.
CLINICA NEUROL, 48: 835|843, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Diagnosis and treatment of dystonia
Ryuji Kaji, M.D, Ph.D., Kenta Sato, M.D., Wataru Sako, M.D. and Satoshi Goto, M.D, Ph.D.
CLINICA NEUROL, 48: 844|847, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 848|848, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Progress in unravelling the etiology of multiple sclerosis?
Makoto Matsui, M.D., Ph.D.
CLINICA NEUROL, 48: 849|852, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Aphasia in practice -recent progress-
Mika Otsuki
CLINICA NEUROL, 48: 853|856, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Pathophysiology of migraine -migraine generator-
Junichi Hamada, M.D.
CLINICA NEUROL, 48: 857|860, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Prion disease -The present status and recent progress in Japan-
Hidehiro Mizusawa, M.D., Ph.D.
CLINICA NEUROL, 48: 861|865, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Diagnosis and management for acute ischemic stroke
Kazumi Kimura, M.D.
CLINICA NEUROL, 48: 866|870, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Limbic Encephalitis and Variants Related to Neuronal Cell Membrane Autoantigens
Josep Dalmau, MD, PhD
CLINICA NEUROL, 48: 871|874, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Dysphagia rehabilitation
Eiichi Saitoh, M.D., DM.Sc.
CLINICA NEUROL, 48: 875|879, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 880|883, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
How do we manage genetic testing for neurodegenerative diseases?
Kunihiro Yoshida, M.D.
CLINICA NEUROL, 48: 884|887, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 888|888, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
A new era has begun since the approval of thrombolytic therapy for acute ischemic stroke in Japan
Kazuo Minematsu, M.D., Ph.D.
CLINICA NEUROL, 48: 889|891, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Molecular epidemiology of cerebrovascular diseases; the Hisayama study and the Fukuoka Stroke Registry (FSR)
Takanari Kitazono, M.D.1), Michiaki Kubo, M.D.2), Jun Hata, M.D.3), Setsuro Ibayashi, M.D.4), Yutaka Kiyohara, M.D.3) and Mitsuo Iida, M.D.4)
CLINICA NEUROL, 48: 892|895, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Neuroprotective therapy for ischemic stroke with free radical scavenger and gene-stem cell therapy
Koji Abe, M.D., Ph.D.
CLINICA NEUROL, 48: 896|898, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 899|899, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Development of new systems for monitoring the quality of stroke care in community
Yasuhiro Hasegawa
CLINICA NEUROL, 48: 900|901, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 902|902, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Recent progress and future direction of neurodegenerative disease research
Ryosuke Takahashi, M.D., Ph.D.
CLINICA NEUROL, 48: 903|905, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 906|906, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Targeting the structure and function relationships of the γ-secretase for the development of Alzheimer's disease
Taisuke Tomita, M.D.
CLINICA NEUROL, 48: 907|909, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Neurodegeneration and inflammation: analysis of a FTDP-17 model mouse
Yasumasa Yoshiyama, M.D.
CLINICA NEUROL, 48: 910|912, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Pathomechanism of polyglutamine diseases and strategic design for their therapies
Nobuyuki Nukina, M.D.
CLINICA NEUROL, 48: 913|914, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 915|915, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Relationship between anti-NMDAR encephalitis and acute juvenile female non-herpetic encephalitis (AJFNHE)
Satoshi Kamei, M.D.
CLINICA NEUROL, 48: 916|919, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Clinical features and pathogenesis of anti-NMDA receptor encephalitis
Takahiro Iizuka, M.D.
CLINICA NEUROL, 48: 920|922, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Anti-NMDAR encephalopathy: treatment
Shigeaki Suzuki, M.D., Ph.D., Morinobu Seki, M.D. and Norihiro Suzuki, M.D., Ph.D.
CLINICA NEUROL, 48: 923|925, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Acute limbic encephalitis and NMDA type-glutamate receptor
Yukitoshi Takahashi, M.D.1)2), Etsuko Yamazaki, M.D.1), Shigeko Nishimura, M.D.1), Hisano Tsunogae, M.D.1), Kenji Niwa, M.D.3), Josep Dalmau, M.D.4), Katsumi Imai, M.D.1) and Tateki Fujiwara, M.D.1)
CLINICA NEUROL, 48: 926|929, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 930|930, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
To search for the pathogenesis of multiple sclerosis from the bedside
Jun-ichi Kira, M.D.
CLINICA NEUROL, 48: 931|933, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 934|934, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Approach to find new therapies for MS from clinical view
Masaaki Niino, M.D.
CLINICA NEUROL, 48: 935|936, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Therapeutic strategy against multiple sclerosis
Akio Suzumura, M.D.
CLINICA NEUROL, 48: 937|939, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 940|940, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Aquaporin-4
Kazutoshi Tani, Ph.D., Yoko Hiroaki, Ph.D. and Yoshinori Fujiyoshi, Ph.D.
CLINICA NEUROL, 48: 941|944, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Diffusion tensor imaging
Harushi Mori
CLINICA NEUROL, 48: 945|946, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Functional imaging in Binswanger's disease
Hidekazu Tomimoto, M.D.1)3), Masafumi Ihara, M.D.1), Ryosuke Takahashi, M.D.1) and Hidenao Fukuyama, M.D.2)
CLINICA NEUROL, 48: 947|950, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 951|951, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Introduction of neuroethics: Out of clinic, beyond academia in human brain research
Tamami Fukushi, Ph.D.1) and Osamu Sakura, Ph.D.1)2)
CLINICA NEUROL, 48: 952|954, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 955|957, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 958|960, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
What must we do for patients with ALS in the process of their decision making on TIPPV?
Hina Uetake
CLINICA NEUROL, 48: 961|962, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
From the Patient's View Point
Shoko Mukai
CLINICA NEUROL, 48: 963|964, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 965|965, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Amyotrophic lateral sclerosis with the SOD1 mutations
Masashi Aoki, M.D., Ph.D., Hitoshi Warita, M.D., Ph.D. and Yasuto Itoyama, M.D., Ph.D.
CLINICA NEUROL, 48: 966|969, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Exploration of pathogenesis-associated molecules and development of disease models for sporadic ALS
Fumiaki Tanaka, M.D.1), Masahiro Waza, M.D.1), Jun-ichi Niwa, M.D.2), Masahiko Yamamoto, M.D.3) and Gen Sobue, M.D.1)
CLINICA NEUROL, 48: 970|972, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
The end of life care for the patients with ALS in Japan
Mieko Ogino
CLINICA NEUROL, 48: 973|975, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 976|978, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 979|979, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 980|980, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Lewy body formation in Parkinson's disease: Neurodegeneration or neuroprotection?
Koichi Wakabayashi, M.D.
CLINICA NEUROL, 48: 981|983, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Cellular pathophysiology of Parkinson's disease
Atsushi Takeda, M.D., Naoto Sugeno, M.D., Takafumi Hasegawa, M.D., Michiko Kobayashi, M.D. and Akio Kikuchi, M.D.
CLINICA NEUROL, 48: 984|985, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Therapy of Parkinson's disease -up to date
Miho Murata
CLINICA NEUROL, 48: 986|988, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 989|989, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Frontotemporal dementia (FTD) and genetic mutations including progranulin gene
Tetsuaki Arai, M.D.1), Masato Hasegawa, Ph.D.2), Masugi Nishihara, Ph.D.3), Takashi Nonaka, Ph.D.2), Fuyuki Kametani, Ph.D.2), Mari Yoshida, M.D.4), Yoshio Hashizume, M.D.4), Thomas G Beach, M.D.5), Mitsuya Morita, M.D.6), Imaharu Nakano, M.D.6), Tatsuro Oda, M.D.7), Kuniaki Tsuchiya, M.D.8) and Haruhiko Akiyama, M.D.1)
CLINICA NEUROL, 48: 990|993, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
The significance of the TDP-43 deposition in FTLD-U and ALS
Masato Hasegawa, M.D.1), Tetsuaki Arai, M.D.2), Takashi Nonaka, M.D.1), Fuyuki Kametani, M.D.1), Mari Yoshida, M.D.3), Yoshio Hashizume, M.D.3), Thomas G Beach, M.D.4), Mitsuya Morita, M.D.5), Imaharu Nakano, M.D.5), Tatsuro Oda, M.D.6), Kuniaki Tsuchiya, M.D.7) and Haruhiko Akiyama, M.D.2)
CLINICA NEUROL, 48: 994|997, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Neuropathology of frontotemporal dementia
Shigeo Murayama, M.D., Ph.D.
CLINICA NEUROL, 48: 998|998, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
The early symptoms of frontotemporal lobar degeneration
Koichi Okamoto, M.D.
CLINICA NEUROL, 48: 999|1001, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Symptomatology of fronto-temporal dementia
Manabu Ikeda, M.D.
CLINICA NEUROL, 48: 1002|1004, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 1005|1005, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Pathogenesis and treatment of stroke-like episodes in MELAS
Takahiro Iizuka, M.D.
CLINICA NEUROL, 48: 1006|1009, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
L-arginine therapy on MELAS
Yasutoshi Koga
CLINICA NEUROL, 48: 1010|1012, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
A model mouse for mitochondrial DNA-based diseases
Kazuto Nakada, Ph.D., Akitsugu Sato, Ph.D. and Jun-Ichi Hayashi, Ph.D.
CLINICA NEUROL, 48: 1013|1015, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
New therapeutic strategy for mitochondrial diseases
Yu-ichi Goto
CLINICA NEUROL, 48: 1016|1017, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
CLINICA NEUROL, 48: 1018|1018, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Hereditary neuropathy: recent advance
Masanori Nakagawa, M.D.
CLINICA NEUROL, 48: 1019|1022, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Immune-mediated neuropathy
Susumu Kusunoki, M.D.
CLINICA NEUROL, 48: 1023|1025, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Metabolic and nutritional neuropathy
Naoki Hattori, M.D., Haruki Koike, M.D. and Gen Sobue, M.D.
CLINICA NEUROL, 48: 1026|1027, 2008
The 49th Annual Meeting of the Japanese Society of Neurology
Therapeutic strategy for peripheral nerve regeneration; molecular permeability control at the blood-nerve barrier
Takashi Kanda, M.D., Ph.D.
CLINICA NEUROL, 48: 1028|1030, 2008